About 300 million
people worldwide are living with hepatitis B, yet the majority of cases remain
undiagnosed or untreated, researchers have found. Geoffrey Dusheiko,
emeritus professor of medicine (UCL Institute for Liver and Digestive Health),
said governments need to start addressing HBV in a similar vein to how HIV is
currently screened and managed.
Read
more: The Guardian
Close
